You are here:

Are you an Established Business?

Are you an Established Business?

Capital Solutions
Solutions
Capital Solutions
Solutions

Our clients have the option of tailoring any portfolio of the full-service offerings that they require

At the heart of every trial are patients – people who bear the burden of their condition, but also the challenges of everyday life. Consequently, reliable and responsible trial patient access is the number one challenge facing NME clinical development in the bio/pharmaceutical industry. We work with exclusive long-standing execution partners who have decades of experience in their specific patient target groups. In focusing on their time-tested therapeutic areas, we can increase patient engagement, recruitment and retention; reduce timelines and risks and give more patients the voice – and ultimately, the treatments – they deserve.

Begin with insight & planning

To help optimise our engagement, we start by cycling our clients through a strategic validation process to establish optimal alignment with our capabilities. As an engagement formalises, we build a clear clinical development solutions with cross-interrogation of the trial protocol and clinical development roadmaps. This upfront planning ultimately minimises failure and reduces avoidable costs.

FULL SERVICE OR TAILORED OFFERINGS

We can deliver a full-service offering from protocol design through data management, clinical and bioanalytical procedures as well as statistical analysis and reporting. Our clients have the option of tailoring any portfolio of the full-service offering that they require, and we work closely with them to achieve an optimal service package.

  • Infectious Diseases (Vaccines & Therapeutics)
  • Healthy Volunteers
  • Autoimmune Disorders
  • Chronic Metabolic Disorders (with/out CV complications)
  • Chronic Respiratory Disorders
  • Musculoskeletal Disorders
  • Medical Writing
  • Regulatory Support
  • Clinical Execution
  • Laboratory Procedures
  • Data Management
  • Site Monitoring & Audit

At the heart of every trial are patients – people who bear the burden of their condition, but also the challenges of everyday life. Consequently, reliable and responsible trial patient access is the number one challenge facing NME clinical development in the bio/pharmaceutical industry. We work with exclusive long-standing execution partners who have decades of experience in their specific patient target groups. In focusing on their time-tested therapeutic areas, we can increase patient engagement, recruitment and retention; reduce timelines and risks and give more patients the voice – and ultimately, the treatments – they deserve.

Our clients have the option of tailoring any portfolio of the full-service offerings that they require

Our clients have the option of tailoring any portfolio of the full-service offerings that they require

Begin with insight & planning

To help optimise our engagement, we start by cycling our clients through a strategic validation process to establish optimal alignment with our capabilities. As an engagement formalises, we build a clear clinical development solutions with cross-interrogation of the trial protocol and clinical development roadmaps. This upfront planning ultimately minimises failure and reduces avoidable costs.

FULL SERVICE OR TAILORED OFFERINGS

We can deliver a full-service offering from protocol design through data management, clinical and bioanalytical procedures as well as statistical analysis and reporting. Our clients have the option of tailoring any portfolio of the full-service offering that they require, and we work closely with them to achieve an optimal service package.

  • Infectious Diseases (Vaccines & Therapeutics)
  • Healthy Volunteers
  • Autoimmune Disorders
  • Chronic Metabolic Disorders (with/out CV complications)
  • Chronic Respiratory Disorders
  • Musculoskeletal Disorders
  • Medical Writing
  • Regulatory Support
  • Clinical Execution
  • Laboratory Procedures
  • Data Management
  • Site Monitoring & Audit